Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effects of benralizumab on lung volume changes during exercise in experimental setting in severe asthmatics: a pilot study. | Front Pharmacol | 2025 | 40771920 | PubTator, text mining | PubMed |
| Immunophenotypic and Transcriptomic Analysis of Peripheral Blood Mononuclear Cells in Bullous Pemphigoid. | Ann Dermatol | 2025 | 40736520 | PubTator, text mining | PubMed |
| Genetic analyses of eight complex diseases using predicted continuous representations of disease. | Cell Rep Methods | 2025 | 40714005 | PubTator, text mining | PubMed |
| Transcriptomics in T2-High Severe Asthmatics Treated with Biologics: Comparison between Anti-IgE, Anti-IL-5, and Anti-IL-5 Receptor Treatments. | Am J Respir Cell Mol Biol | 2025 | 40700724 | PubTator, text mining | PubMed |
| The HL-60 clone 15 cell line as a model for leukocyte migration-possibilities and limitations. | Front Immunol | 2025 | 40496865 | PubTator, text mining | PubMed |
| Remarkable increase in Interleukin-5 receptor expression beyond tissue eosinophils in inflammatory bowel disease. | Front Immunol | 2025 | 40475764 | PubTator, text mining | PubMed |
| Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis. | Eur Neuropsychopharmacol | 2025 | 40408832 | PubTator, text mining | PubMed |
| Eosinophilic granulomatosis with polyangiitis: current status and future perspectives. | Respir Investig | 2025 | 40383090 | PubTator, text mining | PubMed |
| Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report. | Allergy Asthma Clin Immunol | 2025 | 40382631 | PubTator, text mining | PubMed |
| Interleukin-4 modulates type I interferon to augment antitumor immunity. | Sci Adv | 2025 | 40367186 | PubTator, text mining | PubMed |
| High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor. | Respir Med | 2025 | 40345261 | PubTator, text mining | PubMed |
| Transcriptomic and metabolomic insights into neutrophil activity in COPD complicated by metabolic syndrome. | Biomed Eng Online | 2025 | 40234868 | PubTator, text mining | PubMed |
| Effect of benralizumab treatment on the airway microbiome in COPD. | ERJ Open Res | 2025 | 40196715 | PubTator, text mining | PubMed |
| Response to IL-5/IL-5R Antagonists and Remission Rate in Patients With Severe Asthma Who Would Have Been Excluded From the Pivotal Clinical Trials. | J Allergy Clin Immunol Pract | 2025 | 40154738 | PubTator, text mining | PubMed |
| Differential methylation in blood pressure control genes is associated to essential hypertension in African Brazilian populations. | Epigenetics | 2025 | 40143670 | PubTator, text mining | PubMed |
| Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD. | Respir Res | 2025 | 40133927 | PubTator, text mining | PubMed |
| Effectiveness of anti-IL-5/5Rα biologics in severe asthma in real-world studies: a systematic review and meta-analysis. | ERJ Open Res | 2025 | 40129552 | PubTator, text mining | PubMed |
| Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study. | J Allergy Clin Immunol Pract | 2025 | 40113138 | PubTator, text mining | PubMed |
| Antiviral roles of eosinophils in asthma and respiratory viral infection. | Front Allergy | 2025 | 40083723 | PubTator, text mining | PubMed |
| [Guidelines for the prevention and management of bronchial asthma (2024 edition)]. | Zhonghua Jie He He Hu Xi Za Zhi | 2025 | 40050074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=8